Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapy

B Niu, K Liao, Y Zhou, T Wen, G Quan, X Pan, C Wu - Biomaterials, 2021 - Elsevier
Glutathione (GSH) is an important member of cellular antioxidative system. In cancer cells, a
high level of GSH is indispensable to scavenge excessive reactive oxygen species (ROS) …

[HTML][HTML] Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma

D Du, C Liu, M Qin, X Zhang, T Xi, S Yuan… - … Pharmaceutica Sinica B, 2022 - Elsevier
Hepatocellular carcinoma (HCC) is an aggressive human cancer with increasing incidence
worldwide. Multiple efforts have been made to explore pharmaceutical therapies to treat …

Endoplasmic reticulum stress signals in the tumour and its microenvironment

X Chen, JR Cubillos-Ruiz - Nature Reviews Cancer, 2021 - nature.com
Protein handling, modification and folding in the endoplasmic reticulum (ER) are tightly
regulated processes that determine cell function, fate and survival. In several tumour types …

Glutamine reliance in cell metabolism

HC Yoo, YC Yu, Y Sung, JM Han - Experimental & molecular medicine, 2020 - nature.com
As knowledge of cell metabolism has advanced, glutamine has been considered an
important amino acid that supplies carbon and nitrogen to fuel biosynthesis. A recent study …

Mechanisms of metabolic reprogramming in cancer cells supporting enhanced growth and proliferation

C Schiliro, BL Firestein - Cells, 2021 - mdpi.com
Cancer cells alter metabolic processes to sustain their characteristic uncontrolled growth
and proliferation. These metabolic alterations include (1) a shift from oxidative …

Cell-programmed nutrient partitioning in the tumour microenvironment

BI Reinfeld, MZ Madden, MM Wolf, A Chytil, JE Bader… - Nature, 2021 - nature.com
Cancer cells characteristically consume glucose through Warburg metabolism, a process
that forms the basis of tumour imaging by positron emission tomography (PET). Tumour …

Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion

RD Leone, L Zhao, JM Englert, IM Sun, MH Oh, IH Sun… - Science, 2019 - science.org
The metabolic characteristics of tumors present considerable hurdles to immune cell
function and cancer immunotherapy. Using a glutamine antagonist, we metabolically …

Tumor microenvironment signaling and therapeutics in cancer progression

A Goenka, F Khan, B Verma, P Sinha… - Cancer …, 2023 - Wiley Online Library
Tumor development and metastasis are facilitated by the complex interactions between
cancer cells and their microenvironment, which comprises stromal cells and extracellular …

Mechanisms and implications of metabolic heterogeneity in cancer

J Kim, RJ DeBerardinis - Cell metabolism, 2019 - cell.com
Tumors display reprogrammed metabolic activities that promote cancer progression. We
currently possess a limited understanding of the processes governing tumor metabolism in …

Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer

DN Edwards, VM Ngwa, AL Raybuck… - The Journal of …, 2021 - Am Soc Clin Investig
Rapidly proliferating tumor and immune cells need metabolic programs that support energy
and biomass production. The amino acid glutamine is consumed by effector T cells and …